At a glance
ClinicalIndex Comparison RecordPhase 3Completed· 506 enrolled
Drug / intervention
Fimasartan +1 moredrug
Likely dose
Fimasartan 120mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Randomized, Double-blind, Losartan-controlled, Parallel Group Comparison Dose Titration Clinical Study to Evaluate the Antihypertensive Efficacy and Safety of Fimasartan 60mg~120mg in Patients With Mild to Moderate Essential Hypertension
In Brief
A Phase 3 clinical trial evaluating Fimasartan and Losartan (Control) for Hypertension. Completed, enrolled 506 participants.
Detailed Summary
The purpose of this study is to evaluate the antihypertensive efficacy and safety of Fimasartan (BR-A-657•K) 60 mg\~120 mg in patients with mild to moderate essential hypertension.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHypertension
Countries--
CollaboratorsSeoul National University Hospital, The Catholic University of Korea, Kangbuk Samsung Hospital, Konkuk University Medical Center, Konyang University Hospital, Keimyung University, Korea University, Korea University Guro Hospital, Dongguk University International Hospital, Seoul National University Bundang Hospital, Samsung Medical Center, Asan Medical Center, Severance Hospital, Ajou University, Wonju Severance Christian Hospital, Yeungnam University Hospital, Yonsei University, Inha University Hospital, Chonbuk National University Hospital, Cheil General Hospital and Women's Healthcare Center, Chungnam National University, Chungbuk National University Hospital, Hanyang University
Timeline
Phase 3CompletedFinished
200920102011201220132014201520162017201820192020202120222023202420252026
Enrollment StartDec 2008
First PostedJun 2009
Primary CompletionJul 2009
Study CompletionSep 2009
TodayJul 2026
First PostedJun 17, 2009
Enrollment StartDec 1, 2008
Primary CompletionJul 1, 2009
Study CompletionSep 1, 2009
TodayJul 2, 2026
Enrollment to primary: 7 monthsPosted 17.0 years ago
Interventions
Fimasartandrug
Fimasartan 60 \~ 120mg/po take one tablets once a day
Losartan (Control)drug
Losartan 50 mg \~ 100 mg/po, take one tablets once a day